James A. Feldman
Director/Board Member at Washington National Opera
Profile
James A.
Feldman is currently the Director at The Shakespeare Theatre Co. and a Trustee at Washington National Opera.
He previously served as the President & Chief Executive Officer at Van Allen, Inc. from 1971 to 1991.
He was also an Independent Director at Neogenix Oncology, Inc. from 2009 to 2012.
Additionally, he was the President-Law Review at Harvard University.
Feldman holds graduate degrees from both Columbia University and Harvard University, and an undergraduate degree from the University of Pennsylvania.
James A. Feldman active positions
| Companies | Position | Start |
|---|---|---|
Washington National Opera
 Washington National Opera Movies/EntertainmentConsumer Services Washington National Opera operates as an opera company. The company was founded in 1956 and is headquartered in Washington, DC. | Director/Board Member | 2009-11-15 |
The Shakespeare Theatre Co.
 The Shakespeare Theatre Co. Movies/EntertainmentConsumer Services The Shakespeare Theatre Co. operates an American theatrical performing arts company. The non-profit company is based in Washington. | Director/Board Member | - |
Former positions of James A. Feldman
| Companies | Position | End |
|---|---|---|
| Van Allen, Inc. | President | 1990-12-31 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Neogenix Oncology, Inc.
 Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Director/Board Member | - |
Training of James A. Feldman
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Harvard University | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Neogenix Oncology, Inc.
Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Health Technology |
The Shakespeare Theatre Co.
The Shakespeare Theatre Co. Movies/EntertainmentConsumer Services The Shakespeare Theatre Co. operates an American theatrical performing arts company. The non-profit company is based in Washington. | Consumer Services |
Washington National Opera
Washington National Opera Movies/EntertainmentConsumer Services Washington National Opera operates as an opera company. The company was founded in 1956 and is headquartered in Washington, DC. | Consumer Services |
| Van Allen, Inc. |
- Stock Market
- Insiders
- James A. Feldman
